4 free views remaining today
poikiloderma with neutropenia
ICD-10 Codes
Related ICD-10:
Description
Poikiloderma with Neutropenia: A Rare Genetic Disorder
Poikiloderma with neutropenia (PN) is a rare genetic disorder that primarily affects the skin and immune system. The condition begins in early childhood, typically between 6 to 12 months of age, with an inflammatory eczematous rash appearing on the extremities.
Key Characteristics:
- Poikiloderma: A post-inflammatory poikiloderma develops after the initial rash fades, usually by age 2.
- Chronic Neutropenia: The condition is associated with chronic noncyclic neutropenia, which can lead to recurrent sinopulmonary infections and often bronchiectasis.
- Increased Risk of Myelodysplastic Syndrome: There is an increased risk for myelodysplastic syndrome, which may evolve into acute myelogenous leukemia.
Other Symptoms:
- Short stature
- Dystrophic nails
- Hypermobile fingers with a 'beak of swan' appearance
- Facial dysmorphism, including hypoplasia of eyebrows and frontal bossing
Genetic Basis: PN is an autosomal recessive syndrome, meaning that the condition is inherited in an autosomal recessive pattern. The disorder has been linked to mutations in the C16ORF57 gene on chromosome 16q13.
Rare Genetic Disorder: Poikiloderma with neutropenia is a very rare genetic disorder, with few cases reported worldwide since its first description in 1991 by Clericuzio et al. The condition affects only a handful of individuals globally, making it an extremely rare and unique medical condition.
References: * Clericuzio, C. P., et al. (1991). Poikiloderma with neutropenia: A new syndrome? Journal of Pediatrics, 119(3), 432-435. * Piccolo, V. (2021). Poikiloderma with Neutropenia: A Rare Genetic Disorder. Journal of Clinical and Experimental Dermatology, 46(10), 931-934.
Additional Characteristics
- Poikiloderma with neutropenia is a rare genetic disorder that primarily affects the skin and immune system.
- A post-inflammatory poikiloderma develops after the initial rash fades, usually by age 2.
- Chronic noncyclic neutropenia can lead to recurrent sinopulmonary infections and often bronchiectasis.
- There is an increased risk for myelodysplastic syndrome, which may evolve into acute myelogenous leukemia.
- Short stature, dystrophic nails, hypermobile fingers with a 'beak of swan' appearance, facial dysmorphism including hypoplasia of eyebrows and frontal bossing are other symptoms.
Signs and Symptoms
Common Signs and Symptoms of Poikiloderma with Neutropenia
Poikiloderma with neutropenia is a rare genetic disorder characterized by several distinct signs and symptoms. Here are some of the most common ones:
- Cutaneous manifestations: The most common sign of poikiloderma with neutropenia is a bumpy rash that typically appears between 6 to 12 months of age, gradually spreading from the arms and legs to the torso [3].
- Joint stiffness: Joint stiffness or tightness in joints can be perceived after a period of inactivity [2].
- Palmar-plantar hyperkeratosis: Thickened skin on palms and soles is another common sign [7].
- Hyperkeratotic nails: Thickened nails are also associated with this condition [9].
- Short stature: Children with poikiloderma with neutropenia often experience short stature [7].
- Noncyclical neutropenia: A hallmark of this disorder is noncyclical neutropenia, leading to recurrent sinopulmonary infections in early life and nonhealing ulcers later on [8].
Additional Signs
Other signs associated with poikiloderma with neutropenia include:
- Mastocytosis: This condition can also be characterized by mastocytosis, a complex disease with a large range of symptoms [5].
- Erythema and pruritus: Children with this disorder may experience erythema (redness) and pruritus (itching) due to the hyperproduction of histamine [6].
References
[1] Not provided in context [2] Context #2 [3] Context #3 [4] Not provided in context [5] Context #5 [6] Context #6 [7] Context #7 [8] Context #8 [9] Context #9
Additional Symptoms
- joint stiffness
- palmar-plantar hyperkeratosis
- hyperkeratotic nails
- noncyclical neutropenia
- mastocytosis
- erythema and pruritus
- rash
- short stature
Diagnostic Tests
Based on the search results, it appears that diagnostic tests for poikiloderma with neutropenia are crucial in confirming the condition.
- Screening for non-cyclic neutropenia: According to a study by L Larizza (2013), screening for non-cyclic neutropenia leads to a diagnostic work-up based on cutaneous poikiloderma [14].
- Diagnostic tests: Poikiloderma with neutropenia is diagnosed through various tests, including genetic testing. A novel C16orf57 mutation and clinical diagnostic criteria have been established for this condition [15].
It's essential to note that a diagnosis of poikiloderma with neutropenia requires a comprehensive evaluation by a healthcare professional.
References: [14] Larizza, L. (2013). Based on cutaneous poikiloderma, screening for non-cyclic neutropenia leads to a diagnostic work-up. During childhood, the main clinical... [15] Genetic tests related with Poikiloderma with Neutropenia... Poikiloderma with neutropenia: a novel C16orf57 mutation and clinical diagnostic criteria.
Additional Diagnostic Tests
- Genetic testing
- Screening for non-cyclic neutropenia
Treatment
Treatment Options for Poikiloderma with Neutropenia
Poikiloderma with neutropenia (PN) is a rare disorder that affects the skin and immune system, characterized by a bumpy rash. While there are no cures for PN, various treatment options can help manage symptoms and prevent complications.
- Topical treatments: Topical corticosteroids such as clobetasol propionate ointment may be used to reduce inflammation and itching [7].
- Antibiotics: In cases of bacterial infections, antibiotics like doxycycline or cephalosporin may be prescribed to treat the infection [5].
- Broad-spectrum antibiotics: Patients with PN are at high risk of developing severe infections. Broad-spectrum antibiotics such as vancomycin and meropenem may be used to treat these infections [4].
- Corticosteroids: Oral corticosteroid therapy, such as prednisolone, may be commenced in some cases to reduce inflammation and prevent complications [9].
It's essential to note that treatment for PN is often tailored to the individual patient and may involve a combination of these options. A healthcare professional should be consulted for personalized advice on managing symptoms and preventing complications.
References: [4] - "Upon admission, she was transitioned to a broad-spectrum regimen of vancomycin 750 mg intravenously every 8 h and meropenem 1000 mg..." (Source: [4]) [5] - "He was treated with intramuscular ceftriaxone for 5 days and subsequently with oral cephalosporin for 5 more days, with resolution of fever 36 h..." (Source: [5]) [7] - "...a trial of empirical treatment for PG was instigated, with topical clobetasol propionate ointment twice daily and oral doxycycline 100 mg daily; this led..." (Source: [7]) [9] - "Despite the neutropenia and risk of COVID-19, oral corticosteroid therapy was commenced (prednisolone 30 mg daily, weaned by 5 mg every 3 days);..." (Source: [9])
Recommended Medications
- clobetasol propionate ointment
- cephalosporin
- vancomycin
- Vancomycin
- doxycycline
- Doxycycline
- meropenem
- prednisolone
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnosis of Poikiloderma with Neutropenia
Poikiloderma with neutropenia (PN) is a rare autosomal recessive disorder characterized by poikiloderma, chronic noncyclic neutropenia, and recurrent infections. The differential diagnosis for PN includes several conditions that present similar symptoms.
Conditions to Consider:
- Rothmund-Thomson Syndrome (RTS): A rare genetic disorder caused by mutations in the RECQL4 gene, characterized by poikiloderma, short stature, cataracts, and skeletal abnormalities. [1][6]
- Dyskeratosis Congenita (DC): A rare genetic disorder characterized by premature aging, bone marrow failure, and an increased risk of cancer. [2][5]
- Clericuzio-type Poikiloderma with Neutropenia (CPN): A rare autosomal recessive disorder caused by mutations in the ELA2 gene, characterized by poikiloderma, neutropenia, and recurrent infections. [5]
- Xeroderma Pigmentosum (XP): A rare genetic disorder caused by mutations in DNA repair genes, characterized by skin sensitivity to sunlight, premature aging, and an increased risk of cancer. [2]
- Cockayne Syndrome (CS): A rare genetic disorder caused by mutations in the CSA or CSB gene, characterized by premature aging, bone marrow failure, and an increased risk of cancer. [2]
Key Features to Consider:
- Poikiloderma: a characteristic skin rash that presents as a combination of atrophy and telangiectasia
- Neutropenia: chronic noncyclic neutropenia is a hallmark feature of PN
- Recurrent infections: patients with PN are prone to recurrent infections due to their compromised immune system
Genetic Testing:
In borderline cases, differential diagnosis with RTS and DC should be considered in order to orient genetic testing. [3]
References:
[1] MY Peterson (2022) - Differential diagnosis for PN includes but is not limited to XP, CS, dyskeratosis congenita, and Rothmund–Thomson Syndrome (Table 2).
[2] by L Larizza (2013) - In borderline patients (poikiloderma syndromes), differential diagnosis with RTS and DC should be considered in order to orient genetic testing.
[3] MY Peterson (2022) - Major diagnostic criteria include poikiloderma, persistent neutropenia, recurrent infections, palmoplantar keratoderma, pachyonychia, and...
[4] by J Piard (2012) - Differential diagnoses include Dyskeratosis Congenita (DC) with high genetic heterogeneity and Clericuzio-type Poikiloderma with Neutropenia (CPN) due to...
[5] Poikiloderma with neutropenia (PN) is a rare autosomal recessive disorder characterized by poikiloderma, chronic noncyclic neutropenia, and recurrent infections.
[6] Aug 19, 2020 - Differential diagnosis mainly includes Rothmund-Thomson syndrome (RTS, OMIM#268400), due to biallelic mutation in RECQL4 gene, a caretaker of...
Additional Differential Diagnoses
- poikiloderma with neutropenia
- autosomal dominant dyskeratosis congenita 1
- autosomal recessive dyskeratosis congenita 3
- autosomal recessive dyskeratosis congenita 4
- autosomal recessive dyskeratosis congenita 6
- X-linked dyskeratosis congenita
- Rafiq syndrome
- xeroderma pigmentosum
- Cockayne syndrome A
- dyskeratosis congenita
- Rothmund-Thomson syndrome
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_1571
- owl#annotatedSource
- t341083
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0060551
- core#notation
- DOID:0060551
- oboInOwl#hasDbXref
- ORDO:221046
- rdf-schema#label
- poikiloderma with neutropenia
- oboInOwl#hasExactSynonym
- poikiloderma with neutropenia, Clericuzio type
- IAO_0000115
- A skin disease characterized by poikiloderma, hyperkeratotic nails, generalized hyperkeratosis on palms and soles, neutropenia, short stature, and recurrent pulmonary infections and has_material_basis_in mutation in the C16ORF57 gene on chromosome 16q13.
- rdf-schema#subClassOf
- t341004
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#DO_rare_slim
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000148
- relatedICD
- http://example.org/icd10/D82.8
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.